REFERENCES
- Costa L, GaRafrio C, Franca F, deL Giglio A. SimuLtaneous occur-rence of Hodgkin disease and tubercuLosis: report of three cases. South Med J. 2004; 97: 696–8.
- Tu Lasi N, Raju P, Damodaran V, Radhika T. A spectrum of coexis-tent tubercuLosis and carcinoma in the breast and axiLLary Lymph nodes: report of five cases. Breast 2006; 15:437–9.
- Pandey U, Naraynan M, Karnik U, Sinha B. Carcinoma metastasis to unexpected synchronous LymphoproLiferative disorder: report of three cases and review of Literature.] Clin Pathol. 2003; 56: 970–1.
- Etkind P, Du J, Khan A, PiLLitteri J, Wiernik P. Mouse mammary tumor virus-Like ENV gene sequences in human breast tumors and in a Lymphoma of a breast cancer patient. Clin Cancer Res. 2000; 6: 1273–8.
- MoreLLo K, Wurz G, DeGregorio M. Pharmacokinetics of seLective estrogen receptor moduLators. Clin Pharmacokinet. 2003; 42: 361–72.
- Sartor CI. Postmastectomy Radiotherapy in Intermediate-risk Patients:The Gray Zone. Curr OncoE Rep. 2006 Jan;8(1):29–34.